Jose Ruiz Lopez-rekin lankidetzan egindako argitalpenak (6)

2017

  1. New Acridine Thiourea Gold(I) Anticancer Agents: Targeting the Nucleus and Inhibiting Vasculogenic Mimicry

    ACS Chemical Biology, Vol. 12, Núm. 6, pp. 1524-1537

2016

  1. Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization

    Chemical Communications, Vol. 52, Núm. 98, pp. 14165-14168

2015

  1. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study

    Journal of Medicinal Chemistry, Vol. 58, Núm. 18, pp. 7310-7327

  2. Synthesis of 2-pyridyl-benzimidazole iridium(III), ruthenium(II), and platinum(II) complexes. study of the activity as inhibitors of amyloid-β aggregation and neurotoxicity evaluation

    Inorganic Chemistry, Vol. 54, Núm. 2, pp. 470-475

2013

  1. Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: Synthesis, structural characterization, and biological activity

    Inorganic Chemistry, Vol. 52, Núm. 23, pp. 13529-13535

  2. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes

    Chemical Communications, Vol. 49, Núm. 98, pp. 11533-11535